BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35743167)

  • 1. Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents.
    Bašová P; Paszeková H; Minařík L; Dluhošová M; Burda P; Stopka T
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
    Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells.
    Vezzali F; Grassilli S; Lambertini E; Brugnoli F; Patergnani S; Nika E; Piva R; Pinton P; Capitani S; Bertagnolo V
    J Cell Mol Med; 2018 Jun; 22(6):3149-3158. PubMed ID: 29532991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.
    Gerloff D; Grundler R; Wurm AA; Bräuer-Hartmann D; Katzerke C; Hartmann JU; Madan V; Müller-Tidow C; Duyster J; Tenen DG; Niederwieser D; Behre G
    Leukemia; 2015 Mar; 29(3):535-47. PubMed ID: 25092144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
    Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
    Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
    Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs.
    Wang X; Jin P; Zhang Y; Wang K
    Cell Death Dis; 2021 Mar; 12(4):297. PubMed ID: 33741901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
    Curik N; Burda P; Vargova K; Pospisil V; Belickova M; Vlckova P; Savvulidi F; Necas E; Hajkova H; Haskovec C; Cermak J; Krivjanska M; Trneny M; Laslo P; Jonasova A; Stopka T
    Leukemia; 2012 Aug; 26(8):1804-11. PubMed ID: 22343522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
    Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
    Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
    Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
    Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
    Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
    [No Abstract]   [Full Text] [Related]  

  • 16. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
    Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
    Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML.
    Barth J; Abou-El-Ardat K; Dalic D; Kurrle N; Maier AM; Mohr S; Schütte J; Vassen L; Greve G; Schulz-Fincke J; Schmitt M; Tosic M; Metzger E; Bug G; Khandanpour C; Wagner SA; Lübbert M; Jung M; Serve H; Schüle R; Berg T
    Leukemia; 2019 Jun; 33(6):1411-1426. PubMed ID: 30679800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
    Yang H; Liang H; Yan JS; Tao R; Hao SG; Ma LY
    Int J Hematol; 2012 Jul; 96(1):65-73. PubMed ID: 22674382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P; Chan S
    Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.